CELL POINT (INDIA) LTD Fair Value
CELLPOINT · Consumer Services · Current price ₹16.45
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹34 | 3% ROE fading to 14% over ~3 yrs, on ₹40 book |
| Relative P/E | ₹64 | EPS × 70.4 peer-median P/E |
| Graham floor | ₹29 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is CELL POINT (INDIA) LTD undervalued?
DocStoX estimates the fair value of CELL POINT (INDIA) LTD at ₹42 per share, versus the current market price of ₹16. That puts the stock about +153.2% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹34), Relative P/E (₹64), Graham floor (₹29). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹29 (bear) to ₹42 (base) to ₹64 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on CELL POINT (INDIA) LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.